HB2628 authorizes pharmacists in Arizona who are already permitted to order and administer medications to also administer emergency medications when a patient has an acute allergic reaction to a medication given at the pharmacy. The bill defines emergency medications to include epinephrine, corticosteroids, albuterol, oxygen, and antihistamines. It is aimed at allowing pharmacists to respond immediately to adverse reactions that occur on-site, rather than waiting for outside medical assistance.
The bill also requires pharmacists to notify the patient’s identified primary care provider or physician within 48 hours after administering the emergency medication, using pharmacy records or information from the patient or a parent/guardian to identify the provider. Pharmacists must also follow the pharmacy’s or institution’s standard operating procedures and emergency management policies. In addition, the bill states that it does not create a cause of action against a patient’s primary care provider or physician for adverse outcomes arising from the pharmacist’s emergency administration of medication when the provider did not write the prescription order for that emergency medication.
Impact
HB2628 amends Title 32, Chapter 18, Article 3 of the Arizona Revised Statutes by adding section 32-1974.01 to expand the scope of pharmacist authority in emergency response situations. It affects the Arizona State Board of Pharmacy by allowing it to adopt rules governing notification and implementation, and it affects pharmacies, pharmacists, patients, and potentially primary care providers or physicians by clarifying duties and limiting liability exposure in specified circumstances.
Sentiment
The bill appears to have received broad bipartisan support and little visible opposition. It passed the House and Senate committees and floor votes unanimously or overwhelmingly, with no recorded dissent in the provided vote history. The lack of committee transcripts suggests there was no major public controversy captured in the available materials, and the vote pattern indicates general agreement that the measure improves patient safety and pharmacy practice.
Contention
The main policy issue in the bill is the balance between expanding pharmacist authority to treat acute allergic reactions and ensuring appropriate follow-up and accountability. The notification requirement to the patient’s primary care provider or physician reflects concern about continuity of care, while the liability-limiting language in subsection C may be intended to protect physicians from being blamed for emergency treatment they did not order. Any potential contention would likely center on scope-of-practice questions, emergency treatment protocols, and whether pharmacists should be authorized to administer these medications without a direct prescription order in the moment.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.